Progestogen only contraception in women with congenital heart disease-Reference-Cited by-同舟云学术

Progestogen only contraception in women with congenital heart disease

Published:2024-03-11 Issue:1 Volume:44 Page:
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Baró-Mariné Francesc¹,Pijuan-Domènech Antonia²³,Goya Maria del Mar¹,Suárez-Edo Elena⁴,Miranda-Barrio Berta²³,Dos-Subirà Laura²³,Pancorbo Maria Luisa¹,Ferreira-Gonzalez Ignacio³⁵,Carreras-Moratonas Elena¹

Affiliation:

1. Department of Obstetrics and Gynaecology, University Hospital Vall d’Hebron, Barcelona, Spain

2. Integrated Hospital Vall d’Hebron-Hospital Sant Pau Adult Congenital Heart Disease Unit, University Hospital Vall d’Hebron, Barcelona, Spain

3. Department of Cardiology, University Hospital Vall d’Hebron, CIBER-CV, Barcelona, Spain

4. Department of Anesthesiology, Hospital Vall d’Hebron, Barcelona, Spain

5. Department of Cardiology, University Hospital Vall d’Hebron, CIBER-ESP, Barcelona, Spain

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2024.2320296

Reference22 articles.

1. Safety of contraceptive use among women with congenital heart disease: A systematic review

2. Anon, et al., 2015. WHO guidelines approved by the guidelines review committee. Medical eligibility criteria for contraceptive use. Geneva: World Health Organization.

3. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

4. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association;Cannobio M.;Circulation,2017

5. Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report